Cat# NEZ030005MC; Chromium-51 Radionuclide Sodium chromate in normal saline, 5mCi, Quote#: Q-129559

Revvity Health Sciences, Inc. has been awarded contract A207_PO-0481191-V2 by the University of Virginia on September 29, 2026. The contract carries a cumulative value of $1,393.14. While specific details regarding the products and services to be delivered under this prime contract award are not enumerated in the provided documentation, the contractor's industry classification as a health sciences entity suggests the deliverables likely align with laboratory, diagnostic, or analytical health science solutions.

The contract documentation does not specify the period of performance, annual value, total contract amount, county of performance, or specific places of performance. These details would typically be contained in the full contract file or purchase order documentation. To obtain comprehensive information regarding the scope of work, performance milestones, and service delivery locations, reference should be made to the complete contract terms and conditions maintained by the University of Virginia's procurement office.